XAB2
Basic information
Region (hg38): 19:7619525-7629545
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the XAB2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 52 | 52 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 53 | 1 | 1 |
Variants in XAB2
This is a list of pathogenic ClinVar variants found in the XAB2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-7619602-C-T | not specified | Uncertain significance (Feb 14, 2024) | ||
19-7619608-A-G | not specified | Uncertain significance (Jun 16, 2023) | ||
19-7619621-G-A | not specified | Uncertain significance (May 02, 2023) | ||
19-7619624-C-T | not specified | Uncertain significance (Aug 25, 2021) | ||
19-7619641-C-A | not specified | Uncertain significance (Aug 14, 2024) | ||
19-7619642-G-A | not specified | Uncertain significance (Jun 26, 2024) | ||
19-7619765-T-C | not specified | Uncertain significance (Jun 01, 2023) | ||
19-7619783-C-A | not specified | Uncertain significance (Oct 12, 2024) | ||
19-7619786-C-T | not specified | Uncertain significance (Sep 08, 2024) | ||
19-7619827-T-C | not specified | Uncertain significance (Jun 07, 2023) | ||
19-7619842-C-T | not specified | Uncertain significance (Oct 22, 2021) | ||
19-7619950-C-T | not specified | Uncertain significance (Jan 17, 2024) | ||
19-7619958-A-G | not specified | Uncertain significance (Nov 10, 2024) | ||
19-7619971-C-T | not specified | Uncertain significance (May 12, 2024) | ||
19-7619979-G-A | not specified | Uncertain significance (Jun 16, 2024) | ||
19-7619988-C-T | not specified | Uncertain significance (Oct 27, 2022) | ||
19-7619989-G-A | not specified | Uncertain significance (Feb 23, 2023) | ||
19-7620003-G-A | not specified | Uncertain significance (Apr 15, 2024) | ||
19-7620040-C-T | not specified | Uncertain significance (Feb 17, 2022) | ||
19-7620076-C-A | Uncertain significance (Oct 16, 2018) | |||
19-7620283-G-A | not specified | Uncertain significance (May 27, 2022) | ||
19-7620361-C-T | not specified | Uncertain significance (Apr 09, 2024) | ||
19-7620412-A-G | not specified | Uncertain significance (Feb 24, 2022) | ||
19-7620425-T-G | not specified | Uncertain significance (Aug 09, 2021) | ||
19-7620436-G-A | not specified | Uncertain significance (Jan 20, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
XAB2 | protein_coding | protein_coding | ENST00000358368 | 19 | 10041 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.973 | 0.0272 | 125718 | 0 | 30 | 125748 | 0.000119 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.94 | 471 | 605 | 0.779 | 0.0000450 | 5537 |
Missense in Polyphen | 127 | 182.89 | 0.69439 | 1539 | ||
Synonymous | -1.36 | 280 | 252 | 1.11 | 0.0000195 | 1661 |
Loss of Function | 5.43 | 9 | 50.8 | 0.177 | 0.00000260 | 520 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000958 | 0.0000958 |
Ashkenazi Jewish | 0.0000997 | 0.0000992 |
East Asian | 0.0000546 | 0.0000544 |
Finnish | 0.000140 | 0.000139 |
European (Non-Finnish) | 0.0000882 | 0.0000879 |
Middle Eastern | 0.0000546 | 0.0000544 |
South Asian | 0.000425 | 0.000425 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in pre-mRNA splicing as component of the spliceosome (PubMed:11991638, PubMed:28502770, PubMed:28076346). Involved in transcription-coupled repair (TCR), transcription and pre-mRNA splicing (PubMed:10944529, PubMed:17981804). {ECO:0000269|PubMed:10944529, ECO:0000269|PubMed:11991638, ECO:0000269|PubMed:17981804, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770}.;
- Pathway
- Spliceosome - Homo sapiens (human);DNA Repair;Metabolism of RNA;mRNA Splicing - Major Pathway;Formation of TC-NER Pre-Incision Complex;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Nucleotide Excision Repair
(Consensus)
Recessive Scores
- pRec
- 0.192
Intolerance Scores
- loftool
- 0.306
- rvis_EVS
- -1.37
- rvis_percentile_EVS
- 4.48
Haploinsufficiency Scores
- pHI
- 0.684
- hipred
- Y
- hipred_score
- 0.809
- ghis
- 0.594
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.921
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Xab2
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype;
Gene ontology
- Biological process
- generation of catalytic spliceosome for first transesterification step;mRNA splicing, via spliceosome;blastocyst development;transcription-coupled nucleotide-excision repair;transcription, DNA-templated;cerebral cortex development
- Cellular component
- Prp19 complex;nucleus;nucleoplasm;membrane;U2-type catalytic step 2 spliceosome;catalytic step 2 spliceosome;post-mRNA release spliceosomal complex
- Molecular function
- protein binding